Company Search:
Advanced Search
Sponsored Links
AC Immune SA Company Snapshot
AC Immune SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares AC Immune SA with three other companies in this sector in the United States: ProQR Therapeutics NV (2018 sales of $6.79 million of which 100% was Pharmaceutical), Voyager Therapeutics Inc ($7.62 million of which 100% was Clinical-stage gene therapy company), and DarioHealth Corp ($7.39 million ).

Sales Analysis. AC Immune SA reported sales of $7.36 million for the year ending December of 2018. This represents a sharp decrease of 64.4% versus 2017, when the company's sales were $20.66 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
AC Immune SA
  Stock Performance Chart for AC Immune SA
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): 5.05
(Figures in U.S. Dollars)
1 Week -1.0%   13 Weeks -6.1%  
4 Weeks -14.1%   52 Weeks -37.7%  
AC Immune SA Key Data:
  Ticker: ACIU Country: Switzerland
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 7,364,066
(Year Ending Jan 2019).
Employees: 116
  Currency: U.S. Dollars Market Cap: 341,189,782
  Fiscal Yr Ends: December Shares Outstanding: 67,562,333
  Share Type: Common Closely Held Shares: 34,910,131
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.